S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery (S0931)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Southwest Oncology Group
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group
ClinicalTrials.gov Identifier:
NCT01120249
First received: May 7, 2010
Last updated: July 21, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2021 (Final data collection date for primary outcome measure)